Literature DB >> 32063773

Relapsed angioimmunoblastic T-cell lymphoma with large pericardial effusion.

Rahul Sawhney1,2, Randy D Volkmer2, Barry Cooper1,2,3.   

Abstract

T-cell lymphomas comprise 10% to 15% of all lymphoid malignancies and affect precursor or mature T cells; the latter are referred to as peripheral T-cell lymphomas. We present a case of a subtype, angioimmunoblastic T-cell lymphoma, in which a patient previously treated with chemotherapy and autologous stem cell transplant relapsed with B symptoms and large pericardial/pleural effusions. Recurrent lymphoma was confirmed on pericardial tissue biopsy. Treatment was trialed with lenalidomide and the effusions resolved. Five months later she died from septic shock and multiorgan failure. Our case highlights the need for rapid evaluation of B symptoms and/or new effusions in patients with a known history of angioimmunoblastic T-cell lymphoma.
Copyright © 2020 Baylor University Medical Center.

Entities:  

Keywords:  AITCL; AITL; angioimmunoblastic T-cell lymphoma; malignant effusion; pericardial effusion

Year:  2019        PMID: 32063773      PMCID: PMC6988641          DOI: 10.1080/08998280.2019.1668720

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  16 in total

1.  Neoplasms involving the heart, their simulators, and adverse consequences of their therapy.

Authors:  W C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-10

2.  CT and PET/CT findings of T-cell lymphoma.

Authors:  Hansel J Otero; Jyothi P Jagannathan; Luciano M Prevedello; Ciaran J Johnston; Nikhil H Ramaiya; Annick D Van den Abbeele; Pamela J DiPiro
Journal:  AJR Am J Roentgenol       Date:  2009-08       Impact factor: 3.959

3.  Cardiac Tamponade as Initial Presentation of Angioimmunoblastic T-Cell Lymphoma.

Authors:  Xu Zhang; Ji Chao Zhang; Rong Xing Liu; Qi Miao
Journal:  Heart Surg Forum       Date:  2017-03-06       Impact factor: 0.676

4.  Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10.

Authors:  Ayoma Attygalle; Rajai Al-Jehani; Tim C Diss; Phillipa Munson; Hongxiang Liu; Ming-Qing Du; Peter G Isaacson; Ahmet Dogan
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

5.  Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics.

Authors:  Noha Botros; Lorenzo Cerroni; Allam Shawwa; Peter J Green; Wenda Greer; Sylvia Pasternak; Noreen M Walsh
Journal:  Am J Dermatopathol       Date:  2015-04       Impact factor: 1.533

Review 6.  Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.

Authors:  Matthew A Lunning; Julie M Vose
Journal:  Blood       Date:  2017-01-23       Impact factor: 22.113

7.  Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.

Authors:  Massimo Federico; Thomas Rudiger; Monica Bellei; Bharat N Nathwani; Stefano Luminari; Bertrand Coiffier; Nancy L Harris; Elaine S Jaffe; Stefano A Pileri; Kerry J Savage; Dennis D Weisenburger; James O Armitage; Nicholas Mounier; Julie M Vose
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

8.  High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Charalampia Kyriakou; Carmen Canals; Anthony Goldstone; Dolores Caballero; Bernd Metzner; Guido Kobbe; Hans-Jochem Kolb; Joachim Kienast; Peter Reimer; Jurgen Finke; Gunnar Oberg; Ann Hunter; Niklas Theorin; Anna Sureda; Norbert Schmitz
Journal:  J Clin Oncol       Date:  2008-01-10       Impact factor: 44.544

9.  Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma.

Authors:  Francine Foss; Barbara Pro; H Miles Prince; Lubomir Sokol; Dolores Caballero; Steven Horwitz; Bertrand Coiffier
Journal:  Cancer Med       Date:  2016-12-16       Impact factor: 4.452

Review 10.  The aggressive peripheral T-cell lymphomas: 2017.

Authors:  James O Armitage
Journal:  Am J Hematol       Date:  2017-07       Impact factor: 10.047

View more
  2 in total

Review 1.  Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma.

Authors:  Mostafa F Mohammed Saleh; Ahmed Kotb; Ghada E M Abdallah; Ibrahim N Muhsen; Riad El Fakih; Mahmoud Aljurf
Journal:  Curr Oncol       Date:  2021-12-20       Impact factor: 3.677

2.  The Early Diagnostic Dilemma in Angioimmunoblastic T Cell Lymphoma with Excessive Plasma Cells Proliferation.

Authors:  Chunyan Wang; Xia Mao; Songya Liu; Cheng He; Ying Wang; Li Zhu; Yangyang Wang; Yicheng Zhang
Journal:  Case Rep Med       Date:  2021-07-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.